• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE INTRA-ARTICULAR HYALURONIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE INTRA-ARTICULAR HYALURONIC ACID Back to Search Results
Lot Number 7RSL021
Device Problem Device Contamination With Biological Material (2908)
Patient Problem No Code Available (3191)
Event Date 12/12/2017
Event Type  malfunction  
Event Description
This spontaneous case from united states was received on 20-apr-2018 from patient this case concerns (b)(6) female patient who initiated treatment with synvisc one and after an unknown latency she was limiting around; had swollen knee and her whole leg was swollen, swollen knee and my whole leg was swollen; knee blew up; after 9 days had aspirated her knee. It was reported that patient received the contaminated shot (synvisc-one) no previous medications and concurrent conditions were reported. Patient had arthritis and had her right knee replaced and took paracetamol (tylenol) and naproxen sodium (aleve) whenever required (concomitant medication). On (b)(6) 2017, patient received treatment with intra articular synvisc one injection at a dose of 6 ml (frequency and indication: unknown) (batch/ lot number: 7rsl021 and expiry date: 31-may-2020). On (b)(6) 2017 after a latency of 9 days, patient had her knee aspirated which was horrible. Patient was limiting around and using a cane. On an unknown date after an unknown latency patient had swollen knee and her whole leg was swollen. Patient took tramadol and tylenol as corrective treatment: not reported for swollen knee and my whole leg was swollen; cane user for i was limiting around; cleaned out, tramadol and tylenol for aspirated my knee outcome: unknown for all events. Seriousness criteria: disability for received the contaminated shot (synvisc-one) and i was limiting around an investigation was initiated as a result of an unexpected increase in the number of labelled adverse events received from the us market for synvisc one, lot 7rsl021. The product met all release testing at time of manufacture in june 2017. Retain samples were retested due to the unexpected increase in adverse events. Higher than expected endotoxin results were obtained. In addition, the presence of microbial contamination was also confirmed. The cause of these events is under investigation. Once this investigation is completed, corrective and preventive actions will be implemented. Pharmacovigilance comment: sanofi company comment 25-apr-2018: this case concerns a patient who has received synvisc one injection on left knee from the recalled lot and had swelling of knee(unspecified) leading to cleaning of the affected knee. It is unknown whether the event occurred in the injected knee. Moreover, the concerned lot number has been identified to have malfunction by the company. Therefore, the causal relationship of the events to the products cannot be excluded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSYNVISC ONE
Type of DeviceINTRA-ARTICULAR HYALURONIC ACID
Manufacturer (Section D)
GENZYME BIOSURGERY (RIDGEFIELD)
1125 pleadantview terrace
ridgefield NJ 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive
55b-220a
bridgewater, NJ 08807
9089817289
MDR Report Key7483496
MDR Text Key107995408
Report Number2246315-2018-00469
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P940015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient
Remedial Action Recall
Type of Report Initial
Report Date 04/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Lot Number7RSL021
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received04/20/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device?
Type of Device Usage Initial

Patient Treatment Data
Date Received: 05/03/2018 Patient Sequence Number: 1
-
-